ClotTriever® Thrombectomy System Use-Result Survey in Japan

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages Any age
• All sexes
• No healthy volunteers
• Child, Adult, Older adult

Study population: All patients with deep vein thrombosis with acute severe symptoms (excluding postthrombotic syndrome) for whom the ClotTriever® Thrombectomy System was used. Patients will be enrolled until at least 100 subjects complete the follow-up period through 6 months.

Trial locations and contacts

15 sites in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Conditions

Deep Vein Thrombosis

Being tested

ClotTriever® Thrombectomy System

Medical subject headings

Venous Thrombosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• ClotTriever® Thrombectomy SystemDevice

  ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Rate of Major Adverse Events

   Rate of Major Adverse Events [All-cause mortality, Major bleeding, New symptomatic Pulmonary Embolism (PE) documented by Computed Tomography Pulmonary Angiography (CTPA), Rethrombosis of a Target Venous Segment].

   Measured: Through 30 days post index procedure.

2. Technical Success

   Thrombus residual volume assessed by the the treating physician using pre- and post-procedure venography to evaluate the success of thrombus removal.

   Measured: During the index procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted12 Mar 2025
2. Study start17 Feb 2025
3. Primary completionMar 2028 (estimated)
4. Study completionDec 2028 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Deep Vein ThrombosisStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.